Published 11 hours ago • loading... • Updated 11 hours agoShow Less IconModerna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2% Summary by 24/7 Wall St.Moderna shares are surging ahead of a closely watched cancer data presentation in Madrid, but the company's razor-thin revenue base means a single readout could swing the stock sharply in either direction.Share menu1 Articles1 ArticlesAllLeftCenter1RightSearch IconSort Icon24/7 Wall St.CenterFactualityOwnershipModerna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2%Moderna shares are surging ahead of a closely watched cancer data presentation in Madrid, but the company's razor-thin revenue base means a single readout could swing the stock sharply in either direction.11 hours ago·Lakewood, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right0Center1Last Updated11 hours agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to Vantage24/7 Wall St. broke the news in Lakewood, United States 11 hours ago on Tuesday, October 20, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsModerna Plus IconStock Markets Plus IconMadrid, Spain Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsModerna Plus IconStock Markets Plus IconMadrid, Spain Plus IconShow All